Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial
(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13, the two highest tested...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.